Clinical Trial

An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2025 (before its estimated February 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess the efficacy (ability to produce a desired or intended result) of a topical product (applied to the skin) to improve skin lightness, skin condition and appearance (hyperpigmentation \[dark spots\], brightness/radiance \[healthy vibrant appearance\], skin texture \[smoothness\]) on \] the face over a period of eighteen (18) weeks. The data collected may support the company in developing marketing claims for its product.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-20; most recent amendment 2026-05-22.
Status change: Enrolling by Invitation → Completed 2026-04-23
Trial Details
NCT Number NCT07136766
Lead Sponsor Good Molecules, LLC
Collaborators: Validated Claim Support
Conditions Hyperpigmentation
Enrollment 40 participants
Start Date 2025-09-10
Primary Completion 2026-02-16 (estimated)
Study Completion 2026-02-16 (estimated)
Updated on ClinicalTrials.gov 2025-08-22